Pathogenesis and transmission of swine origin A(H3N2)v influenza viruses in ferrets by Pearce, Melissa B. et al.
Pathogenesis and transmission of swine origin
A(H3N2)v inﬂuenza viruses in ferrets
Melissa B. Pearcea, Akila Jayaramanb, Claudia Pappasa, Jessica A. Belsera, Hui Zenga, Kortney M. Gustina,
Taronna R. Mainesa, Xiangjie Suna, Rahul Ramanb, Nancy J. Coxa, Ram Sasisekharanb, Jaqueline M. Katza,
and Terrence M. Tumpeya,1
aInﬂuenza Division, Centers for Disease Control and Prevention, Atlanta, GA 30333; and bHarvard–MIT Division of Health Sciences and Technology,
Singapore–MIT Alliance for Research and Technology, Department of Biological Engineering, Koch Institute for Integrative Cancer Research, Massachusetts
Institute of Technology, Cambridge, MA 02139
Edited by Peter Palese, Mount Sinai School of Medicine, New York, NY, and approved January 18, 2012 (received for review December 5, 2011)
Recent isolation of a novel swine-origin inﬂuenza A H3N2 variant
virus [A(H3N2)v] from humans in the United States has raised con-
cern over the pandemic potential of these viruses. Here, we ana-
lyzed the virulence, transmissibility, and receptor-binding pref-
erence of four A(H3N2)v inﬂuenza viruses isolated from humans
in 2009, 2010, and 2011. High titers of infectious virus were de-
tected in nasal turbinates and nasal wash samples of A(H3N2)v-
inoculated ferrets. All four A(H3N2)v viruses possessed the capac-
ity to spread efﬁciently between cohoused ferrets, and the 2010
and 2011 A(H3N2)v isolates transmitted efﬁciently to naïve ferrets
by respiratory droplets. A dose-dependent glycan array analysis of
A(H3N2)v showed a predominant binding to α2-6–sialylated gly-
cans, similar to human-adapted inﬂuenza A viruses. We further
tested the viral replication efﬁciency of A(H3N2)v viruses in a rele-
vant cell line, Calu-3, derived fromhumanbronchial epithelium. The
A(H3N2)v viruses replicated in Calu-3 cells to signiﬁcantly higher
titers compared with ﬁve common seasonal H3N2 inﬂuenza vi-
ruses. These ﬁndings suggest that A(H3N2)v viruses have the ca-
pacity for efﬁcient replication and transmission in mammals and
underscore the need for continued public health surveillance.
Seasonal epidemics and periodic pandemics are an ever-presentinternational public health burden. During seasonal epi-
demics, the risk for hospitalization and death are highest among
persons at either end of the age spectrum as well as for indi-
viduals with underlying medical conditions (1, 2). Although the
overall impact of the 2009 inﬂuenza pandemic, caused by an
H1N1 virus [A(H1N1)pdm09] was more modest than those of
prior pandemics, the disproportionate disease burden among
children and younger adults distinguished this pandemic from
seasonal inﬂuenza (3–5). The A(H1N1)pdm09 virus emerged
from swine, with a unique constellation of genes from human,
avian, and swine inﬂuenza viruses not previously observed in
nature. Swine represent a unique host because of their ability to
be infected by inﬂuenza viruses from multiple species and serve
as a reservoir for speciﬁc subtypes of inﬂuenza capable of
infecting humans (6–8). Triple-reassortant swine (TRS) H1N1
viruses, which share host gene-lineage origins with A(H1N1)
pdm09 viruses, have been responsible for sporadic human cases
since 2005 (9, 10). The emergence of the A(H1N1)pdm09 virus,
to which the majority of children and younger adults had little
preexisting immunity, highlights the public health threat posed
by other swine-origin inﬂuenza virus subtypes.
H3N2 viruses have circulated in humans since their pandemic
emergence in 1968 and are generally associated with uncompli-
cated disease in young healthy adults. However, epidemics caused
by H3N2 viruses have been more severe than those caused by
seasonal H1N1 or inﬂuenza B viruses (11, 12). In 1997–1998,
human H3N2 viruses infected swine and spread widely in North
American swine (6–8). In particular, TRS H3N2 viruses with
a human lineage polymerase subunit polymerase basic 1 (PB1)
gene, avian lineage PB2 and polymerase acidic (PA) genes, and
swine lineage nucleoprotein (NP), matrix (M), and nonstructural
(NS) genes, referred to as the triple-reassortant internal gene
(TRIG) constellation, have been isolated widely in pigs throughout
the United States (6–8, 13). From the late 1990s to 2009, these
novel variants of H3N2 viruses [A(H3N2)v] were limited to
transmission among swine, with only occasional detections of
transmission to humans (14). However, between September and
November 2010, ﬁve cases of human infection with the novel
swine-origin A(H3N2)v were reported (15). Although all ﬁve
recovered fully from their illness, two of the ﬁve cases were hos-
pitalized. In 2011, 12 additional human cases were documented in
the United States, with limited human-to-human transmission in
some cases (15–17). The 2011 A(H3N2)v viruses are similar to
other A(H3N2)v viruses isolated from previous human infections
over the past 2 y but are unique in that the M gene is derived from
the A(H1N1)pdm09 virus. Antigenic characterization showed
that the A(H3N2)v viruses are distinct from current seasonal
H3N2 viruses but exhibit a low degree of serologic cross-reactivity
with human H3N2 viruses that circulated in the early 1990s (6, 8,
13), suggesting that children born after this time period may be
particularly susceptible to infection.
The use of the ferret model has become indispensable for
understanding the virulence and transmission of inﬂuenza viru-
ses (18–20), partly because ferrets and humans share similar lung
physiology as well as because human and avian inﬂuenza viruses
exhibit similar patterns of binding to sialic acids, the receptor for
inﬂuenza viruses distributed throughout the respiratory tract in
both species (21, 22). In this study, we used glycan microarrays to
determine the receptor-binding preference of the A(H3N2)v
viruses isolated from humans. The culture model of bronchial
epithelial Calu-3 cells was used to assess viral replication, and the
ferret model was used to assess pathogenicity and transmissibility.
Notably, the 2010 and 2011 swine-origin H3N2 viruses replicated
even more efﬁciently than human seasonal inﬂuenza viruses in
human airway Calu-3 cells and exhibited efﬁcient respiratory-
droplet (RD) transmission in ferrets. These ﬁndings suggest that
swine-origin H3N2 viruses have the potential to cause additional
human disease.
Results
Pathogenesis of A(H3N2)v Inﬂuenza Viruses in Ferrets. We charac-
terized four A(H3N2)v viruses isolated in 2009, 2010, and 2011
from patients with uncomplicated upper respiratory tract illness.
A/Kansas/13/2009 (KS/09) was isolated from a 12-y-old male
who presented with fever, cough, and sore throat after contact
with healthy-appearing swine while attending a county fair (14).
A/Minnesota/11/10 (MN/10) virus was isolated from a 37-y-old
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male who reported exposure to pigs, whereas A/Pennsylvania/14/
10 (PA/10) virus was isolated from a 45-y-old male with no
known swine exposure (15). A/Indiana/08/11 (IN/11) virus was
isolated from a male child <5 y old who may have been indirectly
exposed through his caregiver (16). We ﬁrst compared the
pathogenesis of the A(H3N2)v viruses in ferrets inoculated with
106 pfu of virus. For each virus group, three ferrets were ob-
served for clinical signs of illness and also served as inoculated
animals for transmission studies. Ferrets inoculated with each of
the A(H3N2)v viruses exhibited moderate weight loss, with the
mean maximum loss ranging from 8.3% to 10.8% and a maxi-
mum mean body temperature increase of ∼1.4 °C (Table 1). All
four viruses replicated efﬁciently in the upper respiratory tract;
high viral titers (≥5.2 log10 pfu/mL) were measured in nasal wash
samples. Mild lethargy was observed among all inoculated ferrets
only during peak times of viral shedding [1–5 d postinoculation
(dpi)], and all animals recovered fully from the infection.
Three additional inoculated ferrets were humanely euthanized
on 3 dpi for determination of viral titers in the respiratory tract
(nasal turbinates, trachea, and lungs), brain tissue (and olfactory
bulbs), intestinal tract (duodenum, jejunum, and descending co-
lon), and spleen. High viral titers were detected in nasal turbinates
from ferrets inoculated with each of the 2010–2011 A(H3N2)v
viruses; mean titers ranged from 5.5 to 7.3 log10 pfu/mL (Fig. 1 A–
C). Although IN/11 and MN/10 viruses were not detected in tra-
chea or lungs, PA/10 virus was detected in the trachea of two of
three ferrets (mean 5.4 log10 pfu/g) and in lung tissue of one ferret
(1.95 log10 pfu/g). In contrast to the more recent A(H3N2)v
viruses, the 2009 (KS/09) virus replicated efﬁciently throughout
the respiratory tract in all three ferrets (Fig. 1D). With the ex-
ception of trace amounts of virus (5–6 pfu/g) detected in the brain
and intestinal tissues of a single ferret (Fig. 1), no infectious virus
was recovered from extrapulmonary tissues, suggesting a general
lack of systemic spread of A(H3N2)v viruses in ferrets.
Transient mild lymphopenia has been reported previously
after infection of ferrets with seasonal inﬂuenza viruses, whereas
infection with highly pathogenic avian inﬂuenza viruses can re-
sult in a substantial reduction in lymphocytes (>20% from
baseline levels) (23, 24). To assess the impact of novel A(H3N2)v
virus infection on the lymphohemopoetic system, we performed
complete blood counts taken before infection, 3 dpi, and 21 dpi.
Compared with baseline levels, a signiﬁcant decrease in the total
percentage of lymphocytes (13–24% reduction, P < 0.004) was
detected on 3 dpi in ferrets infected with all A(H3N2)v viruses
(Table 1). In all virus groups, the lymphopenia observed at 3 dpi
resolved by 21 dpi, with leukocyte parameters returning to pre-
inoculation (baseline) levels.
Transmissibility of A(H3N2)v Viruses. To evaluate the trans-
missibility of A(H3N2)v viruses, both RD and direct-contact
(DC) transmission experiments were performed. For the DC
transmission model, a naïve contact ferret was introduced into
the same cage as each inoculated ferret 1 d after inoculation.
For RD transmission experiments, naïve ferrets were placed in
adjacent cages with modiﬁed walls containing perforations to
allow for air exchange while restricting physical contact between
animals (25). RD transmission is a more stringent test of virus
transmissibility because it requires virus to be transmitted only
through the exchange of air containing virus particles. Trans-
mission was assessed by titration of infectious virus in nasal
washes and measurement of hemagglutination inhibition (HI)
titers in convalescent sera of contact ferrets. All four A(H3N2)v
viruses transmitted efﬁciently in the DC model; virus was
detected in nasal washes in all contact ferrets as early as 1 d
postcontact (dpc) (Fig. S1), and seroconversion was conﬁrmed
in all animals (Table 1).
The 2010–2011 A(H3N2)v viruses, MN/10, PA/10, and IN/11,
transmitted efﬁciently by RD to three of three RD contact fer-
rets as early as 1 dpc, and all contact ferrets shed virus and
seroconverted at levels similar to those of inoculated animals
(Table 1 and Fig. 2 A–C). A repeat experiment was performed
with MN/10 virus to conﬁrm efﬁcient RD transmission, and
similar results held for both 100% transmission (three of three
positive-contact ferrets) and early (1–3 dpc) spread of virus to
RD contact ferrets. The 2009 H3N2 virus, KS/09, spread to only
two of three RD contact ferrets, and the kinetics of transmission
was delayed by 5 or more dpc (Fig. 2D). In general, RD contact
ferrets exhibited similar symptoms of fever and lethargy compared
with A(H3N2)v-inoculated ferrets (Table 1). Altogether, these
data demonstrate that the 2010–2011 A(H3N2)v viruses replicated
efﬁciently in ferrets and readily transmitted in both the DC and
RD models, whereas the 2009 A(H3N2)v virus exhibited efﬁcient
DC transmission but less efﬁcient RD transmission.
Glycan Binding Properties of MN/10, PA/10, and KS/09 Viruses. A
comparison of the critical amino acid residues constituting the
HA receptor-binding site (RBS) between MN/10, KS/09, and
PA/10 viruses showed that they were very similar (Table S1).
The RBS of these viruses was composed of characteristic resi-
dues found in other human-adapted seasonal H3N2 viruses,
Table 1. Clinical symptoms of ferrets infected with A(H3N2)v inﬂuenza viruses
Virus
exposure
No. with weight loss (mean
maximum weight loss, %)




at 3 dpi,* %
No. with virus detection
(peak titer, log10 pfu/mL)
No. with seroconversion
(HI geometric mean titer)
IN/11
Inoculated 3/3 (10.8) 3/3 (1.3) 16.6 3/3 (7.1) 3/3 (1280)
DC contact 3/3 (2.8) 3/3 (1.2) ND 3/3 (5.3) 3/3 (1280)
RD contact 3/3 (2.9) 3/3 (1.2) ND 3/3 (5.2) 3/3 (1280)
MN/10
Inoculated 3/3 (8.3) 3/3 (1.1) 23.8 3/3 (5.9) 3/3 (403)
DC contact 3/3 (6.9) 3/3 (0.9) ND 3/3 (5.5) 3/3 (403)
RD contact 3/3 (15.9) 3/3 (1.3) ND 3/3 (5.5) 3/3 (254)
PA/10
Inoculated 3/3 (10.3) 3/3 (1.5) 19.0 3/3 (6.1) 3/3 (806)
DC contact 3/3 (11.5) 3/3 (1.4) ND 3/3 (5.5) 3/3 (640)
RD contact 3/3 (10.8) 3/3 (1.2) ND 3/3 (6.7) 3/3 (640)
KS/09
Inoculated 3/3 (9.1) 3/3 (1.6) 13.2 3/3 (5.2) 3/3 (1015)
DC contact 3/3 (1.5) 3/3 (0.5) ND 3/3 (5.9) 3/3 (806)
RD contact 2/3 (16.5) 2/3 (0.5) ND 2/3 (4.5) 2/3 (453)
ND, not determined.
*Mean percentage decrease in lymphocytes determined at 3 dpi compared with baseline measurements.









including Asp190, a hydrophobic amino acid (such as Val/Ile/
Leu) at 226 instead of Gln (typically found in avian viruses),
and Ser228, which are known to be critically involved in binding
to α2-6–sialylated glycans. However, in comparison with sea-
sonal and 1968 pandemic H3N2 viruses, MN/10, KS/09, and
PA/10 viruses possessed differences in other residues that
contact the glycan receptor, including 156, 137, 193, and 225
(Table S1).
To investigate the glycan receptor-binding properties of
MN/10, KS/09, and PA/10 viruses, we analyzed the binding of
these viruses in a dose-dependent fashion to representative α2-
3– and α2-6–sialylated glycans on a glycan array platform (Fig.
3). All three viruses showed similar predominant binding to
α2-6–sialylated glycans in comparison with α2-3–sialylated
glycans, indicating that their HA had characteristic binding
properties of human-adapted seasonal inﬂuenza viruses. The
predominant binding to α2-6–sialylated glycan receptors by
these viruses is consistent with the characteristic amino acids
in the 190, 226, and 228 positions in the RBS that are typically
found in HA from human-adapted seasonal viruses (26, 27).
The binding characteristics exhibited by the A(H3N2)v viruses
as tested in this glycan array system suggest that these viruses
would replicate efﬁciently in the upper respiratory tract of
humans, where α2-6 sialic acid linkages are more abundant
(21, 22).
A(H3N2)v Viruses Replicate Efﬁciently in Human Airway Epithelial
Cells. Because the airway epithelium is the primary site of in-
ﬂuenza virus replication in humans, we investigated the repli-
cation efﬁciency of the A(H3N2)v viruses in Calu-3 cells,
derived from human bronchial epithelium. Grown on transwell
inserts, the Calu-3 cell line forms polarized monolayers that
resemble the in vivo airway epithelium (28). We compared the
replication kinetics of ﬁve selected seasonal H3N2 viruses to
those of the four A(H3N2)v viruses. Calu-3 monolayers were
inoculated with each virus at a multiplicity of infection (MOI)
of 0.01, and supernatants were collected at the times indicated
and titered for the presence of infectious virus (Fig. 4). With all
viruses tested, titers of progeny virus progressively increased
during the ﬁrst 48 h postinoculation (hpi) Notably, all four
A(H3N2)v viruses exhibited a 26- to 2,600-fold increase in
replication at 48 hpi compared with seasonal H3N2 viruses (P <
0.004). These data demonstrate that the A(H3N2)v viruses
replicate efﬁciently and to high titers in a model of human air-
way epithelial cells.
Discussion
The recent cases of human infection by the A(H3N2)v viruses
have raised public health concerns and highlight the need to
better understand the potential of these viruses to spread and
Fig. 1. Comparison of A(H3N2)v inﬂuenza virus titers recovered from ferret
tissues. Three ferrets were inoculated by the i.n. route with 106 pfu of IN/11
virus (A), MN/10 virus (B), PA/10 virus (C), or KS/09 virus (D), and tissues were
collected 3 dpi. Titers are expressed as log10 pfu per gram of tissue; the limit
of detection was 1.0 log10 pfu/g or mL. Nasal turbinate virus titers are
expressed as log10 pfu/mL Each bar represents one ferret.
Fig. 2. Transmissibility of A(H3N2)v inﬂuenza viruses among ferrets in the
RD model. Three ferrets each were inoculated i.n. with 106 pfu of IN/11 virus
(A), MN/10 virus (B), PA/10 virus (C), or KS/09 virus (D); a naïve ferret was
placed in an adjacent cage at 24 h after inoculation to initiate contact. Nasal
washes were collected from inoculated (dark bars) and contact (light bars)
ferrets, and titers are expressed as log10 pfu/mL. Values for individual ferrets
are shown.
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cause disease in humans. In this study, we characterized four A
(H3N2)v inﬂuenza viruses that were isolated from humans in
2009, 2010, and 2011. In cultured human respiratory epithelial
cells, we observed that the A(H3N2)v viruses replicated to higher
levels than seasonal H3N2 inﬂuenza viruses did, suggesting that
these viruses have the ability to efﬁciently infect cells of the
human airway. We found that the 2010 and 2011 virus isolates,
MN/10, PA/10, and IN/11, replicated efﬁciently in ferrets, caused
morbidity, and transmitted efﬁciently to contact ferrets. These
novel swine-origin A(H3N2)v viruses were also found to possess
human-like (α2-6–linked) receptor-binding properties consistent
with the efﬁcient RD transmission displayed by the 2010 and
2011 virus isolates. These ﬁndings underscore the need for
continued surveillance and characterization of these viruses be-
cause they resemble viruses with pandemic potential.
The ferret model recapitulates the efﬁcient transmission of
seasonal inﬂuenza viruses and the poor transmission of avian in-
ﬂuenza viruses in humans (25, 29–31). The transmission kinetics
and efﬁcient RD transmission of the 2010 and 2011 A(H3N2)v
viruses is comparable to that observed with seasonal inﬂuenza
viruses in ferrets (23, 29, 32, 33). The high titers of virus shedding
observed (peak mean titers 5.2–7.1 log10 pfu/mL) in ferret nasal
washes correlated with the high-growth phenotype of A(H3N2)v
viruses in human airway epithelial cells. The signiﬁcantly higher
release of progeny virus from A(H3N2)v-infected Calu-3 cells
reached levels previously observed in Calu-3 cell cultures infected
with the 1918 pandemic virus (34). The A(H3N2)v viruses induced
morbidity in ferrets (mean maximum weight loss of >8%) and
lymphopenia to levels comparable to the 2009 pandemic and TRS
H1N1 viruses (24, 35–37) but substantially less than those ob-
served with avian H5N1 viruses (23, 38–40).
The binding preference of inﬂuenza viruses for receptors on
cells of the airway epithelium is likely a determinant of efﬁcient
RD transmission (21, 27, 32). Human-adapted seasonal in-
ﬂuenza H1 and H3 HA demonstrate high speciﬁcity for α2-6–
sialylated glycans, and it has been postulated that efﬁcient
and sustained human-to-human transmission of inﬂuenza viru-
ses requires an α2,6 sialic acid receptor-binding preference
(21, 22, 27, 30, 32, 41). Bateman et al. demonstrated that
TRS H3N2 viruses isolated in the late 1990s bound exclusively
to α2-6–sialylated glycans (42). The A(H3N2)v viruses tested
here have retained a human receptor-binding afﬁnity for α2-6–
linked sialic acids, similar to human seasonal H3N2 viruses (43)
despite distinct evolutionary pathways of these viruses since the
introduction of this subtype into the pig population in the late
1990s (6, 8, 13).
Identiﬁcation of the genetic determinants that govern efﬁcient
replication and transmission of A(H3N2)v viruses are needed to
understand the factors that may lead to the emergence of future
swine-origin pandemic inﬂuenza viruses. In comparison with the
Fig. 3. Binding preference of A(H3N2)v inﬂuenza viruses. Dose-dependent
direct glycan array binding of MN/10 (A), KS/09 (B), and PA/10 (C) viruses. 3′
SLN, 3′SLN-LN, and 3′SLN-LN-LN are representative avian receptors, and 6′SLN
and 6′SLN-LN are representative human receptors. The binding signals were
determined based on the HRP activity by using the Amplex Red Peroxidase
Assay (Invitrogen) according to the manufacturer’s instructions. The assays
were done in triplicate, and appropriate negative controls were included.
Fig. 4. Replication kinetics of A(H3N2)v inﬂuenza viruses in polarized hu-
man airway epithelial cells. The seasonal H3N2 viruses are abbreviated as
follows: WI/05, A/Wisconsin/67/2005; PE/10, A/Perth/16/2009; RI/10, A/Rhode
Island/01/2010; WI/10, A/Wisconsin/13/2010; and HK/09, A/Hong Kong/
34341/2009. Calu-3 cells cultured for 1 wk were inoculated with virus at an
MOI of 0.01. Culture supernatants were collected at the times indicated, and
virus titers were determined by standard plaque assay. The titer value
represents the average for three independent wells. Asterisks indicate sta-
tistically signiﬁcant difference between seasonal H3N2 viruses and four A
(H3N2)v viruses at 16, 24, 48, and 72 h, based on Mann–Whitney test (each
was P < 0.004).









2010–2011 A(H3N2)v viruses, the 2009 H3N2 (KS/09) virus
possessed a distinct phenotype in ferrets that included a greater
tropism for lung tissue and reduced RD transmission efﬁciency.
Previous studies with different subtypes of inﬂuenza A viruses
have suggested that the major determinants for viral replication,
pathogenesis, and/or transmission are located in the HA: poly-
merase subunit proteins PB2 and PB1-F2 (30, 32, 44, 45). KS/09
HA and neuraminidase (NA) proteins are phylogenetically dis-
tinct from the 2010–2011 A(H3N2)v viruses, with amino acid
divergence of ∼5% and 5–6% from the 2010–2011 A(H3N2)v
viruses, respectively. The amino acid changes seen in the HA1
subunit are mostly mapping to antigenic sites, with only one
amino acid change located in a receptor-binding region (13) (at
amino acid position 154). As observed in our glycan binding
experiments, none of these changes appear to affect sialic acid
binding pattern, which would suggest a change in virus binding to
cell types in the respiratory tract.
The greatest identity among the A(H3N2)v viruses are in the
proteins PB1 (98–99%), PB2 (99%), and PA (98–99%) as well as
in NP (99–100%) and NS1/nuclear export protein (NEP) (99–
100%) genes. Interestingly, with the exception of the 2011 (IN/
11) virus, the M protein shares 100% identity among the viruses
tested in this study. Genetic analysis of IN/11 virus, as well as the
other 11 2011 A(H3N2)v viruses, revealed that the M gene was
inherited from the A(H1N1)pdm09 virus (16, 17). Although it
has been suggested that the M segment of the A(H1N1)pdm09
virus is important for enhancing RD transmission in the guinea
pig model (36), the IN/11 virus displayed a similar transmis-
sion phenotype to that of the 2010 A(H3N2)v viruses in ferrets.
Thus, it is unclear whether the acquisition of the M gene from
A(H1N1)pdm09 virus enhanced the ability of A(H3N2)v virus to
spread in pigs and infect humans.
Common to all A(H3N2)v viruses, as well as classical swine
viruses, is the glutamic acid (E) at position 627 in PB2, aspartic
acid at position 701, and the serine/arginine (SR) polymorphism
at positions 590/591. The lack of lysine at position 627 and
asparagine at position 701, reported as markers of virus adap-
tation to mammals, replication, and transmissibility, are com-
pensated by the SR polymorphism at positions 590/591 (44).
This change is also present in PB2 of the A(H1N1)pdm09
viruses (10). The greatest genetic difference between the KS/09
and 2010–2011 A(H3N2)v is found in PB1-F2. The two 2010
A(H3N2)v viruses are predicted to produce a full-length 90-aa
protein, and, even though IN/11 produces a truncated 79-aa
protein, presumably it is still functional and localizes to the
mitochondria (46). On the other hand, KS/09 produces a trun-
cated, nonfunctional 57-aa protein similar to seasonal human
viruses. Full-length PB1-F2 has been shown to have proa-
poptotic function (47) and has been related to delayed virus
clearance from lungs, whereas the absence of this protein has
been reported to reduce mortality in mice (48). Because TRS
viruses have a unique genetic combination, additional studies
are needed to fully understand the molecular correlates A
(H3N2)v virus virulence and transmission.
Genetic variation attributable to the gradual accumulation
of HA mutations or genetic reassortment of inﬂuenza A
viruses in pigs is unpredictable and may lead to the generation
of novel inﬂuenza viruses against which a subset of the pop-
ulation lacks serologic immunity. In North America, there are
multiple combinations of TRS inﬂuenza viruses that have
been isolated from healthy-appearing swine, and A(H3N2)v
viruses are one of the most common subtypes circulating in
this species (6–8, 13). The evolution of antigenically distinct
H3N2 viruses in pigs may pose a threat to humans lacking
cross-reactive serologic immunity. The A(H3N2)v viruses
have retained some antigenic properties of human seasonal
inﬂuenza viruses that circulated in the mid-1990s, but they are
antigenically distinct from the contemporary human seasonal
H3N2 vaccine virus, A/Perth/16/2009, and would not be well
covered by the current trivalent vaccine (13). The data pre-
sented in this study suggest that A(H3N2)v viruses have the
capacity for efﬁcient replication and transmission in mammals
and underscore the need for continued public health surveil-
lance of this emerging virus.
Materials and Methods
Viruses. The stocks of IN/11 and MN/10 virus were grown in Madin–Darby
canine kidney cells as previously described (28). PA/10, KS/09, and seasonal
human H3N2 viruses used in the study were grown in the allantoic cavities of
10-d-old embryonated hens’ eggs at 37 °C for 48 h (34, 39). The identities of
virus genes of virus stocks were conﬁrmed by the Centers for Disease Control
and Prevention Inﬂuenza Sequencing Activity, and genetic analysis was
performed with BioEdit 7.0.9.0 (49) and Mega 5.04 programs (50). To de-
termine a pfu titer, stocks of virus were titrated in Madin–Darby canine
kidney cells by using standard plaque assay methods (28). All experiments
were performed in negative-pressure biosafety level 3 laboratories with
enhancements (BSL3+) as outlined in Biosafety in Microbiological and Bio-
medical Laboratories (51).
Ferret Pathogenesis and Transmission Experiments. Animal research was
conducted under the guidance of the Centers for Disease Control and Pre-
vention’s Institutional Animal Care and Use Committee in an Association for
Assessment and Accreditation of Laboratory Animal Care International-
accredited animal facility. Male Fitch ferrets (Triple F Farms) at 6 mo of age
and serologically negative by HI assay for currently circulating inﬂuenza
viruses were used (33). After intranasal (i.n.) inoculation of 106 pfu in 1 mL,
the pathogenesis of each virus was determined (39). RD and DC virus
transmission models were performed as previously described (25). Nasal
washes were collected from ferrets every other dpi or dpc and titered by
plaque assay. Statistical signiﬁcance of virus titers in nasal washes was de-
termined by Student’s t test. Convalescent serum was collected from in-
oculated and contact animals at 21 dpi to assess seroconversion to virus by HI
assay (52). Ferret complete blood count analyses were performed on blood
collected at 0, 3, and 21 dpi as previously described (24).
Dose-Dependent Direct Binding of H3N2 Virus by Glycan Array. A streptavidin
plate array comprising representative biotinylated α2-3– and α2-6–sialylated
glycans as described in Table S2 was used for the analysis (27, 45). 3′SLN, 3′
SLN-LN, and 3′SLN-LN-LN are representative avian receptors, and 6′SLN and
6′SLN-LN are representative human receptors (Table S2). The viruses (hem-
agglutination units HAU titers indicated) were diluted to 250 μL with 1× PBS
+ 1% BSA. Diluted virus in 50 μL was added to each of the glycan-coated
wells and incubated overnight at 4 °C. The primary and secondary antibodies
used to detect binding were ferret anti–MN/10 antisera (1:500 diluted in 1×
PBS + 1% BSA) and anti–ferret HRP-conjugated antibody (1:500 diluted in 1×
PBS + 1% BSA, respectively). After each step, the wells were washed thrice
with 1× PBST (1× PBS + 0.1% Tween-20) followed by 1× PBS. The wells were
blocked with 1× PBS + 1% BSA for 2 h at 4 °C before adding antibodies. The
binding signals were determined based on the HRP activity determined by
using the Amplex Red Peroxidase Assay (Invitrogen) according to the man-
ufacturer’s instructions. The assays were done in triplicate, and appropriate
negative controls were included.
Infection of Calu-3 Human Airway Epithelial Cells. Calu-3 cells were grown in
Eagle’s MEM and seeded onto semipermeable membrane transwell inserts as
previously described (28). Brieﬂy, after conﬁrming transepithelial resistance,
apical inoculation of inﬂuenza viruses at an MOI of 0.01 was performed.
Aliquots of culture supernatant taken postinoculation from triplicate cultures
were titrated for the presence of infectious virus by standard plaque assay.
The statistical signiﬁcance of virus titer data were determined by using Stu-
dent’s t test and unpaired two-tailed Mann–Whitney test.
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